Established in 1974
185,800 clients worldwide
Over 15,000 markets

Monday morning snapshot

A snapshot of the early morning's equity news and key market movements.

Friday night in the US: The Dow Jones closed flat at 16,321, the NASDAQ finished down ten points at 4308 and the S&P 500 ended the day up five points at 1859.

This morning in London: The FTSE 100 is currently down 88 points at 6721.

FX and commodities: GBP/USD is down four pips at $1.6740, EUR/USD is down 21 pips at $1.3779 and USD/JPY is down 42 pips at ¥101.35. Brent crude is up 223 cents at $111.21 and gold is trading at $1347, up $21.85.

Stocks: Individual equity news will take a back seat to the bigger military issues in Ukraine, which are affecting all the major European indices this morning. Royal Bank of Scotland is looking to find partners with which to merge its Irish Ulster Bank, as it continues to asset-strip. Market sage Warren Buffet has carried on reducing his stake in Tesco, the UK’s largest food retailer. There’s more good news for AstraZeneca, as FDA approval has been given for its Bydureon pen.

The day ahead: Today’s G7 meeting will undoubtedly discuss Russia and Ukraine. The weekend’s HSBC final manufacturing figures have come out in line with expectations. Later in the morning we will also see the latest UK manufacturing purchasing manufacturers index, along with the US equivalent in the afternoon. ECB president Mario Draghi is also due to speak this afternoon. He was originally penciled in to discuss the economic and monetary environment in the EU, but he is also likely to cover the broader geo-political issues to the east.

All figures correct at 8.30am. All times London time.

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.